Pfizer shares rise as drug giant pitches ‘clean slate’ for 2024
…
25,105€
1,05%
Echtzeit-Aktienkurs Pfizer
Bid:
Ask:
Nachrichten zur Pfizer Aktie
Pfizer in charts: Biopharma revenue shows sequential improvement in Q4
…
Pfizer’s stock rises as earnings beat expectations, company seeks ‘clean slate’ in 2024
Pfizer stock rose early Tuesday as the drugmaker beat analysts’ earnings expectations and reaffirmed full-year 2024 guidance.…
GM, Pfizer, Ford and Calix rise premarket; UPS, Whirlpool fall By Investing.com
GM, Pfizer, Ford and Calix rise premarket; UPS, Whirlpool fall…
UBS belässt Pfizer auf Neutral - Ziel 29 Dollar
ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Pfizer nach Zahlen zum vierten Quartal auf "Neutral"…
Pfizer beats earnings estimates as declining Covid business performs better than expected
Pfizer reversed roughly $3.5 billion in revenue related to the expected return of 6.5 million doses of its Covid drug,…
Pfizer surprises with Q4 profit as primary-care sales offset covid slump
Pfizer is sticking to its prior 2024 profit forecasts but sees a potential boost from non-covid product sales.…
Pfizer fourth-quarter loss shallower than anticipated By Investing.com
Pfizer fourth-quarter loss shallower than anticipated…
Pfizer posts surprise profit as US returns fewer courses of COVID pill
…
Pfizer posts surprise profit as demand for COVID products better than expected By Reuters
Pfizer posts surprise profit as demand for COVID products better than expected…
Pfizer earnings beat by $0.28, revenue topped estimates By Investing.com
Pfizer earnings beat by $0.28, revenue topped estimates…
DAX höher erwartet: Lufthansa, Bayer, Jungheinrich, BioNTech, Pfizer, Spotify, Microsoft, Alphabet und AMD im Fokus – das ist heute wichtig
Eine schwache Bayer-Aktie hat den DAX am Montag ins Minus gedrückt. Der deutsche Leitindex ging am Ende mit einem Vlerust…
Pfizer (PFE) Q4 Earnings Top, Revenues Miss on COVID Sales Slump
Pfizer (PFE) reports mixed fourth-quarter 2023 results. It re-affirms its 2024 sales and earnings guidance provided in December 2023.…
GM Up on Q4 Beat & Raise; UPS, Pfizer Mixed
Aside from a cavalcade of earnings, Case-Shiller came in lower month over month and JOLTS are out after the open.…
Pfizer Q4 results on deck amid gloomy earnings outlook
…
Global Lidocaine Hydrochloride Market Size/Share Value Projected to Reach USD 838.6 Million By 2032, Growing at 5.7% CAGR: Polaris Market Research
The global Lidocaine Hydrochloride Market size and share is currently valued at USD 512.70 million in 2023. It is anticipated…
Will New Drugs Drive Pfizer (PFE) Sales in Q4 Earnings?
Investor focus is likely to be on the sales numbers of Pfizers (PFE) several newly launched drugs like Abrysvo, Velsipity,…
Where Will Pfizer Be in 10 Years? @themotleyfool #stocks $PFE
Pfizer stock has dropped about 50% from its peak.…
Where Will Pfizer Be in 10 Years?
Pfizer stock has dropped about 50% from its peak.…
Cramers week ahead: Fed meeting, labor report, Big Tech earnings
Tuesday features earnings reports from Pfizer, General Motors, Microsoft, Alphabet, Starbucks and AMD while Apple, Amazon and Meta report Thursday.…
How To Earn $500 A Month From Pfizer Stock Ahead Of Q4 Earnings Print
Pfizer Inc. (NYSE: PFE) is expected to release earnings results for its fourth quarter, before the opening bell on Jan.…
Pfizer Hold
HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Pfizer nach einem milliardenschweren Zukauf von 35 auf 29…
Recombinant Proteins Market revenue to hit USD 9 Billion by 2035, says Research Nester
Leading recombinant proteins market players include Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, GenScript Biotech Corporation, AbbVie Inc.,…
Berenberg senkt Ziel für Pfizer auf 29 Dollar - Hold
HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Pfizer nach einem milliardenschweren Zukauf von 35 auf 29…
Sarcoma Drugs Industry Review 2018-2023 and Forecast 2024-2028 & 2033: Amgen, Bayer, Eisai, Eli Lilly & Company, and GlaxoSmithKline Dominate the Landscape
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Sarcoma Drugs Global Market Report 2024" report has been added…
Why Pfizer Is a Much Better Stock Than You Might Think
Dont write off this big pharma stock because of its current woes.…
Why Pfizer Is a Much Better Stock Than You Might Think @themotleyfool #stocks $PFE
Dont write off this big pharma stock because of its current woes.…
Why Pfizer Is a Much Better Stock Than You Might Think
…
Could Pfizer Stock Help You Retire A Millionaire?
Pfizer shares have slipped in the double digits over the past year.…
Pfizer (PFE) to Report Q4 Earnings: Heres What to Expect
Pfizers (PFE) revenues are expected to have declined in the fourth quarter of 2023 due to a steep decline in…
Minimale Kursveränderung bei Aktie von Pfizer (26,0897 €)
Im US-amerikanischen Wertpapierhandel ist das Wertpapier von Pfizer derzeit unauffällig. Zuletzt zahlten Investoren für das Papier 28,27 US-Dollar. Kaum auffällig…
How To Earn $500 Per Month From Pfizer Stock
…
Why Im Avoiding 6%-Yielding Pfizer Stock
…
Targinta’s CEO to BioStock: “Strong interest in ADCs in 2023”
During 2023, we have witnessed several significant business deals involving Antibody-drug conjugates (ADC), both in preclinical and clinical phase. This…
Is Pfizer Stock a Buy Near 10-Year Lows for Its 6% Dividend Yield?
Pfizer stock is fresh off the lowest price levels shareholders have seen in a decade. Why is PFE stock so…
Better Bull Market Buy: Pfizer vs. Moderna
There could be a light at the end of the COVID-19 tunnel for both of these beaten-down stocks.…
Better Bull Market Buy: Pfizer vs. Moderna
…
Aktienmarkt: Kurs der Pfizer-Aktie im Plus (25,9775 €)
Der Anteilsschein von Pfizer notiert heute ein wenig fester. Das Papier kostete zuletzt 28,29 US-Dollar. Am US-amerikanischen Aktienmarkt hat sich…
Pfizer Insider Convicted in High-Stakes Covid Pill Trading Scandal By Quiver Quantitative
Pfizer Insider Convicted in High-Stakes Covid Pill Trading Scandal…
Ex-Pfizer Employee Convicted of Insider Trading on Covid Pill
A former Pfizer Inc. employee was convicted of using confidential information about the company’s Covid-19 treatment to make illegal options…
Pfizer: CEO Bets His Pension On The Stock - Upgrading To Buy
…
Zinswende beflügelt BioTech! Bayer, Pfizer, FendX, Evotec und MorphoSys auf dem fundamentalen Prüfstand
Der BioTech-Sektor - Der Auftakt lässt noch zu wünschen übrig Der Jahresstart im Sektor Biotechnologie konnte bislang nicht begeistern. Seitwärts…
The weight loss drug market may soon get more crowded. Here are the companies trying to enter the booming space
Wall Street has been focused on Novo Nordisk, Eli Lilly and other large drugmakers hoping to join the weight loss…
Top 5 Life Science ETFs
Taking a position in a life science exchange-traded fund (ETF) provides exposure to a basket of stocks focused on the…
Why one strategist believes Pfizer and two other stocks are buys
David Dietze, senior investment strategist of Peapack Private Wealth Management, tells Quartz why Pfizer, Exxon, and Walgreens could be great…
Pfizer’s Bourla Bets His Pension on Company Stock as CEO Defends Drug Firm
…
Antiemetics Drugs Market Size Projected to Surge USD 5.4 Billion Growth by 2032, Exhibit a CAGR of 5.9%
Antiemetics drugs market size from USD 3.1 billion in 2022 to USD 5.4 billion in 10 years. The rising prevalence…
Im Passing on Pfizer Stock in 2024. Heres Why.
…
Im Passing on Pfizer Stock in 2024. Heres Why.
Pfizers best days might be behind it as demand for its COVID-19 products hits a wall.…
[Latest] Global Bone and Joint Health Supplement Market Size/Share Worth USD 17.17 Billion by 2032 at a 9.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global…